Edwards Lifesciences (EW) EBITDA Margin (2009 - 2026)
Edwards Lifesciences' quarterly EBITDA Margin came in at 28.97% in Q1 2026, up 102.0% year-on-year from 14.34% in Q1 2025, and up 200.94% quarter-over-quarter from 9.63% in Q4 2025.
Edwards Lifesciences has reported EBITDA Margin for 18 years, with the latest figure at 28.97% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 102.0% year-over-year to 28.97%; the trailing twelve-month figure through Mar 2026 stood at 21.37% (down 443.0% YoY), and the FY2025 full-year result was 20.84%, down 451.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 28.97%, up from 9.63% in the prior quarter.
- The five-year high for EBITDA Margin was 45.99% in Q4 2022, with the low at 9.63% in Q4 2025.
- Average EBITDA Margin over 5 years is 27.44%, with a median of 27.38% recorded in 2023.
- Year-over-year, EBITDA Margin jumped 1783 bps in 2022 and plunged 1860 bps in 2023.
- Tracing EW's EBITDA Margin over 5 years: stood at 45.99% in 2022, then sank by 40 bps to 27.38% in 2023, then retreated by 18 bps to 22.56% in 2024, then slumped by 57 bps to 9.63% in 2025, then soared by 201 bps to 28.97% in 2026.
- The last three EBITDA Margin figures came in at 28.97% (Q1 2026), 9.63% (Q4 2025), and 19.77% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 17.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.97% |
| Dec 31, 2025 | 9.63% |
| Sep 30, 2025 | 19.77% |
| Jun 30, 2025 | 26.84% |
| Mar 31, 2025 | 27.95% |
| Dec 31, 2024 | 22.56% |
| Sep 30, 2024 | 25.89% |
| Jun 30, 2024 | 26.76% |
| Mar 31, 2024 | 26.24% |
| Dec 31, 2023 | 27.38% |
| Sep 30, 2023 | 29.43% |
| Jun 30, 2023 | 20.60% |
| Mar 31, 2023 | 31.80% |
| Dec 31, 2022 | 45.99% |
| Sep 30, 2022 | 30.51% |
| Jun 30, 2022 | 33.44% |
| Mar 31, 2022 | 32.72% |
| Dec 31, 2021 | 28.16% |
| Sep 30, 2021 | 29.79% |
| Jun 30, 2021 | 39.40% |
| Mar 31, 2021 | 31.52% |
| Dec 31, 2020 | 29.49% |
| Sep 30, 2020 | 31.36% |
| Jun 30, 2020 | -18.35% |
| Mar 31, 2020 | 31.73% |
| Dec 31, 2019 | 26.47% |
| Sep 30, 2019 | 26.90% |
| Jun 30, 2019 | 24.61% |
| Mar 31, 2019 | 27.61% |
| Dec 31, 2018 | -0.54% |
| Sep 30, 2018 | 27.45% |
| Jun 30, 2018 | 26.71% |
| Mar 31, 2018 | 28.22% |
| Dec 31, 2017 | 37.83% |
| Sep 30, 2017 | 26.05% |
| Jun 30, 2017 | 28.63% |
| Mar 31, 2017 | 33.76% |
| Dec 31, 2016 | 26.21% |
| Sep 30, 2016 | 25.55% |
| Jun 30, 2016 | 27.18% |
| Mar 31, 2016 | 27.29% |
| Dec 31, 2015 | 26.06% |
| Sep 30, 2015 | 25.31% |
| Jun 30, 2015 | 23.80% |
| Mar 31, 2015 | 28.02% |
| Dec 31, 2014 | 24.35% |
| Sep 30, 2014 | 21.32% |
| Jun 30, 2014 | 20.74% |
| Mar 31, 2014 | 17.90% |
| Dec 31, 2013 | 21.75% |
| Sep 30, 2013 | 21.29% |
| Jun 30, 2013 | 24.46% |
| Mar 31, 2013 | 22.85% |
| Dec 31, 2012 | 25.62% |
| Sep 30, 2012 | 21.12% |
| Jun 30, 2012 | 19.88% |
| Mar 31, 2012 | 18.75% |
| Dec 31, 2011 | 20.11% |
| Sep 30, 2011 | 14.51% |
| Jun 30, 2011 | -9.58% |
| Mar 31, 2011 | 19.38% |
| Dec 31, 2010 | 20.54% |
| Sep 30, 2010 | 19.32% |
| Jun 30, 2010 | -5.01% |
| Mar 31, 2010 | 18.41% |
| Dec 31, 2009 | 18.58% |
| Sep 30, 2009 | 17.32% |
| Jun 30, 2009 | 18.63% |